Stock Price
1.30
Daily Change
0.05 4.00%
Monthly
18.18%
Yearly
8.33%
Q2 Forecast
1.22

Actinium Pharmaceuticals reported $-5.13M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
AbbVie USD 1.82B 1.63B Dec/2025
Actinium Pharmaceuticals USD -5.13M 1.75M Sep/2025
Amgen USD 1.33B 1.88B Dec/2025
Bioline Rx USD -977K 2.96M Sep/2025
Capricor Therapeutics USD -30.17M 5.6M Dec/2025
Pfizer USD -1.65B 5.19B Dec/2025